News
For over a year, Polly, from Scotland, has been battling painful dermatitis on her hands, and despite her efforts no ...
A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...
Recent clinical studies have started showing the benefits of using vitamin B12 cream to help manage dermatitis. Vitamin B12 ...
Using a topical steroid on your face is a common one, but perioral dermatitis can also show up if you’re using thick or oily ...
Many people experience an itchy scalp at some point. It’s usually not a sign of a serious medical condition and can, in most ...
3d
MedPage Today on MSNFDA Approves New Option for Chronic HivesThe FDA approved dupilumab (Dupixent) for chronic spontaneous urticaria (CSU) in patients 12 years and older, the first new ...
Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for ...
The FDA approved dupilumab for the treatment of patients 12 years and older with chronic spontaneous urticaria who remain ...
AD is a growing market with an impressive pipeline of new products from current and future players in the field.
With the recent developments in the atopic dermatitis (AD) market, the field is becoming more competitive as novel therapies are soon anticipated to enter the market. This evolution may benefit AD ...
A new study published in the Journal of European Academy of Dermatology and Venerology showed that compared to patients on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results